SciTransfer
Organization

NOX MEDICAL EHF

Icelandic SME developing sleep disorder diagnostic devices and AI-powered digital tools for personalized respiratory health monitoring.

Technology SMEhealthISSME
H2020 projects
3
As coordinator
2
Total EC funding
€3.0M
Unique partners
39
What they do

Their core work

Nox Medical is an Icelandic SME specializing in sleep diagnostics technology and medical devices for detecting sleep disorders. They develop respiratory monitoring tools, including calibrated respiratory inductive plethysmography (RIP) sensors, and have expanded into AI-powered digital diagnostics for sleep-disordered breathing conditions like obstructive sleep apnea. Their work bridges medical device engineering with machine learning to enable personalized sleep healthcare at scale.

Core expertise

What they specialise in

Sleep diagnostics devicesprimary
3 projects

All three H2020 projects (Respiratory Analyzer, Sleep for All, SLEEP REVOLUTION) center on sleep disorder detection and diagnostic tools.

Respiratory monitoring and biomarkersprimary
2 projects

Respiratory Analyzer validated RIP-based biomarkers for diagnosis, and SLEEP REVOLUTION builds on respiratory signal analysis for sleep-disordered breathing.

AI and machine learning for medical diagnosticsemerging
1 project

SLEEP REVOLUTION applies deep learning and AI techniques to digital sleep diagnostics, marking their move into computational health.

Personalized digital healthemerging
1 project

SLEEP REVOLUTION focuses on personalized health care through digital diagnostics and therapy, extending beyond traditional device manufacturing.

Evolution & trajectory

How they've shifted over time

Early focus
Respiratory sensor hardware validation
Recent focus
AI-powered digital sleep diagnostics

Nox Medical began with focused hardware validation — their 2015 Respiratory Analyzer project was a small Phase 1 SME effort to validate a specific respiratory biomarker sensor. By 2016-2018, Sleep for All scaled their ambition to broader sleep diagnostics across patient groups with a full Phase 2 SME instrument. Their most recent involvement in SLEEP REVOLUTION (2021-2025) shows a clear pivot toward AI-driven, digital-first diagnostics, moving from pure device manufacturing into software-intensive personalized health.

Nox Medical is transitioning from a medical device manufacturer into a digital health company, integrating AI and machine learning into their core sleep diagnostics platform.

Collaboration profile

How they like to work

Role: consortium_leaderReach: European18 countries collaborated

Nox Medical started as a self-driven SME, coordinating both of their earlier projects (Respiratory Analyzer and Sleep for All) independently. Their participation in SLEEP REVOLUTION as a partner in a large consortium (39 unique partners across 18 countries) shows they have matured into a company that can contribute specialized expertise within big collaborative efforts. This trajectory — from solo innovator to trusted consortium partner — suggests they are easy to work with and bring concrete technology rather than just ideas.

Through their three projects, Nox Medical has built connections with 39 unique partners across 18 countries, mostly through the large SLEEP REVOLUTION consortium. This gives them a wide European network in the sleep medicine and digital health research community despite being based in Iceland.

Why partner with them

What sets them apart

Nox Medical occupies a rare niche as a dedicated sleep technology SME from Iceland with a complete journey through the EU SME Instrument — from Phase 1 feasibility through Phase 2 commercialization. Few companies combine deep hardware expertise in respiratory monitoring with an active pivot into AI-based digital diagnostics. For consortium builders in sleep medicine or digital health, they offer both proven medical device capabilities and emerging AI competence, backed by real products rather than just research.

Notable projects

Highlights from their portfolio

  • Sleep for All
    EUR 2M SME Instrument Phase 2 grant as coordinator — one of the larger SME awards, focused on making sleep diagnostics accessible to all patient groups.
  • Respiratory Analyzer
    Their founding H2020 project — a Phase 1 SME feasibility study that validated their core RIP biomarker technology and launched their EU funding trajectory.
  • SLEEP REVOLUTION
    Largest project (EUR 990K to Nox Medical) in a major multi-country consortium applying AI and deep learning to revolutionize sleep diagnostics — signals their strategic direction.
Cross-sector capabilities
Digital technologies and AI for medical applicationsWearable sensor technology and signal processingPersonalized medicine and patient stratificationData-driven healthcare and clinical decision support
Analysis note: Profile based on only 3 projects. Early projects lack keyword data, so evolution analysis relies partly on project titles and descriptions. The company is a known commercial entity (Nox Medical) with real products on the market, which adds confidence beyond what the H2020 data alone provides, but this profile strictly reflects EU project evidence.